e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension
Grignola Juan C., Domingo Enric
Source:
Eur Respir J 2015; 45: 1756-1758
Journal Issue:
June
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Grignola Juan C., Domingo Enric. The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension. Eur Respir J 2015; 45: 1756-1758
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
ERS statement on chronic thromboembolic pulmonary hypertension
COVID-19 and the pulmonary circulation
Related content which might interest you:
Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007
The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
Source: Eur Respir Rev 2014; 23: 350-355
Year: 2014
MnTBAP reduces pulmonary vascular remodeling in experimental pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
Source: Eur Respir J 2011; 38: 1453-1460
Year: 2011
Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1483-1485
Year: 2010
Molecular determinants of cardiac and pulmonary vascular remodeling in scleroderma-related pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008
The importance of cardiac function in pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension
Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020
Year: 2020
Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
Year: 2021
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 6-8
Year: 2010
Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension
Source: Eur Respir J, 57 (5) 2003914; 10.1183/13993003.03914-2020
Year: 2021
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006
First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017
Year: 2018
The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
The revolution of pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 361-363
Year: 2016
Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007
Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021
Year: 2021
The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease
Source: Eur Respir J 2013; 41: 217-223
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept